stoxline Quote Chart Rank Option Currency Glossary
PepGen Inc. (PEPG)
5.37  0.47 (9.59%)    12-01 16:00
Open: 4.93
High: 5.48
Volume: 35,859
Pre. Close: 4.9
Low: 4.83
Market Cap: 128(M)
Technical analysis
2023-12-01 4:21:58 PM
Short term     
Mid term     
Targets 6-month :  6.75 1-year :  7.88
Resists First :  5.78 Second :  6.75
Pivot price 4.49
Supports First :  4.5 Second :  3.72
MAs MA(5) :  4.8 MA(20) :  4.56
MA(100) :  5.59 MA(250) :  10.68
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  88.7 D(3) :  75.7
RSI RSI(14): 61.9
52-week High :  20 Low :  3.72
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PEPG ] has closed Bollinger Bands are 25.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.49 - 5.51 5.51 - 5.53
Low: 4.78 - 4.8 4.8 - 4.83
Close: 5.33 - 5.37 5.37 - 5.41
Company Description

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Headline News

Wed, 15 Nov 2023
PepGen Announces Appointment of Howard Mayer, M.D. to Board of ... - WDRB

Wed, 08 Nov 2023
PepGen Reports Third Quarter 2023 Financial Results and Recent ... - Yahoo Finance

Thu, 19 Oct 2023
The Petri Dish: Thermo Fisher makes $3.1B buy; FDA lifts hold on ... - The Business Journals

Fri, 13 Oct 2023
Institutional investors in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) lost 16% last week but have reaped the benefits of longer-term growth - Simply Wall St

Thu, 12 Oct 2023
PepGen Inc. Announces FDA has Lifted the Clinical Hold on its ... - BioSpace

Fri, 01 Sep 2023
PepGen Announces Presentations at the 2023 Myotonic Dystrophy ... - BioSpace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 24 (M)
Shares Float 8 (M)
Held by Insiders 0 (%)
Held by Institutions 97.7 (%)
Shares Short 297 (K)
Shares Short P.Month 248 (K)
Stock Financials
EPS -2.74
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.28
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -27.3 %
Return on Equity (ttm) -46.5 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -3.37
Qtrly Earnings Growth 0 %
Operating Cash Flow -63 (M)
Levered Free Cash Flow -39 (M)
Stock Valuations
PE Ratio -1.97
PEG Ratio 0
Price to Book value 1.01
Price to Sales 0
Price to Cash Flow -2.04
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android